ocrelizumab
roche
['ocrelizumab', 'multiple sclerosis']
and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we can t wait to share our work with you! #ectrims2022
Neuroimmunology Research Groups (Stefan Bittner & Frauke Zipp) Department of Neurology, University Medical Center of the Johannes Gutenberg University Mainz